Zdrowie i gospodarka · 04/05/2016
FDA Announces Draft Guidance for Direct-Acting Antiviral Drugs for Chronic Hepatitis C Treatment
The FDA is releasing a revised draft guidance to help pharmaceutical companies develop effective treatments for chronic hepatitis C using direct-acting antiviral drugs.